FDA warns against potential counterfeit drugs at Baltimore Medicine Shoppe locations

WASHINGTON The Food and Drug Administration is warning consumers who filled prescriptions at two Medicine Shoppe pharmacies located in Baltimore that they might have received drugs that were either expired or suspected counterfeit.

The products in question include:

• Lisinopril (20 milligrams)
• Guaifenesin/Dextromethorphan (600 mg and 1000 mg)
• Gabapentin (100 mg, 300 mg and 400 mg)
• Metoprolol (50 mg)
• Nifedipine (30 mg)
• Diclofenac Sodium (30 mg)
• Glucophage (500 mg Extended Release)
• Glucovance (125 mg and 500 mg)
• Glipizide/Metformin (2.50 mg/250 mg)
• Furosemide (20 mg)
• Tamoxifen Citrate (10 mg)
• Metformin HCl ER (500 mg)
• Calcitrol (0.25 micrograms)

Because the safety and efficacy of the listed drugs has not been established, the FDA is strongly advising consumers who filled prescriptions for these drugs at the two pharmacies to contact their prescribing physician immediately for new prescriptions.